Drugs Made In America Acquisition II Corp.
DMIIR- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002040475
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
63
- +5 vs. Q1 2026
- Total value $3.31M
Superinvestors holding DMIIR
0
- None of the superinvestors held DMIIR at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by DMIIR insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | PPurchaseOrdinary shares | +700K | – | – | 15.08M | +4.9% | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | SSaleOrdinary shares | −7.97M | – | – | 6.71M | −54.3% | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | PPurchaseOrdinary shares · Derivative | +70K | – | – | 700K | – | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Drugs Made In America Acquisition II LLC10% Owner | PPurchaseOrdinary shares | +700K | – | – | 15.08M | +4.9% | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Drugs Made In America Acquisition II LLC10% Owner | SSaleOrdinary shares | −7.97M | – | – | 6.71M | −54.3% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in DMIIR at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Magnetar Financial LLC | 2,700,000 | $228.15K | 0.00% | 00.0% | Unchanged |
| TORONTO DOMINION BANK | 2,707,723 | $216.04K | 0.00% | +11,227+0.4% | Added |
| MMCAP International Inc. SPC | 2,700,000 | $216K | 0.02% | 00.0% | Unchanged |
| MILLENNIUM MANAGEMENT LLC | 2,000,000 | $160K | 0.00% | 00.0% | Unchanged |
| GLAZER CAPITAL, LLC | 1,899,899 | $152K | 0.00% | 00.0% | Unchanged |